Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Topics Community

Article

Molecular Tumor Boards: Realizing Precision Oncology Therapy.

Clinical pharmacology and therapeutics - 1 Feb 2018

Patel Maulik, Kato Shumei M, Kurzrock Razelle

Abstract excerpt

Technological advances in high-throughput next-generation sequencing (NGS) along with advances in computational processes have brought about the dawn of the genomic medicine era. NGS has enabled molecular characterization of malignancies, and facilitated the development and approval of gene- and immune-targeted therapies, both of which impact the mutanome. Clinical implementation of this technology, approval of...

Topics

Join the communities discussing this publication.

Clinical Decision-Making
Data Mining
Evidence-Based Medicine
Interdisciplinary Communication
Medical Oncology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Patient Care Team

Translational Research, Biomedical

Source

Open in PubMed Open full text

Identifiers

PMID: 29134641
DOI: 10.1002/cpt.920
PMCID: PMC5760337

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular Tumor Boards: Realizing Precision Oncology Therapy.PMID 29134641Read ↗

The molecular tumor board—a key element of precision oncologySemantic proximity Read ↗

Molecular Tumor Boards in Clinical Practice.Semantic proximity Read ↗

Molecular profiling for precision cancer therapiesSemantic proximity Read ↗

Precision oncology: separating the wheat from the chaffSemantic proximity Read ↗

Advances in Personalized OncologySemantic proximity Read ↗

Optimized precision oncology through implementation of a comprehensive molecular analysis pipeline - relevance for additional therapeutic options.Semantic proximity Read ↗

Cancer treatment comes to age: from one-size-fits-all to next-generation sequencing (NGS) technologiesSemantic proximity Read ↗

Next-Generation Sequencing in Oncology—A Guiding Compass for Targeted Therapy and Emerging ApplicationsSemantic proximity Read ↗

Advancing molecular tumour boards: highly needed to maximise the impact of precision medicineSemantic proximity Read ↗

Clinical Applications of Next-Generation Sequencing in Precision OncologySemantic proximity Read ↗

Advances in Precision Oncology: From Molecular Profiling to Regulatory-Approved Targeted TherapiesSemantic proximity Read ↗

Enabling Precision Oncology Through Precision DiagnosticsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.